|
CHRONIC FATIGUE SYNDROME |
|||||||||||||
National and International Print Media Coverage
2010 Coverage
2009 Coverage
2008 Coverage 2007 Coverage: 5/07 through 12/07 2007 Coverage: 1/07 through 4/07 2006 Coverage 2010 Coverage
Newsweek includes CFS as one of “History's Mystery Illnesses” in a pictorial essay. (8/23/10)http://www.newsweek.com/photo/2010/08/23/lyme-disease-and-other-mystery-illnesses.html The journal Retrovirology published “Absence of evidence of Xenotropic Murine Leukemia Virus-related virus infection in persons with Chronic Fatigue Syndrome and healthy controls in the United States,” a report by CDC researchers on their attempts to find XMRV in the blood of CFS patients and healthy controls. They concluded, “We did not find any evidence of infection with XMRV in our U.S. study population of CFS patients of healthy controls by using multiple molecular and a seriologic assays. These data do not support an association of XMRV with CFS.” (7/01/10) http://www.retrovirology.com/content/7/1/57 More than 130 other outlets have reported on this study, includingThe CDC’s Journal of Emerging Infectious Diseases reports on “Xenotropic Murine Leukemia Virus–related Gammaretrovirus in Respiratory Tract,” a German study in which researchers looked for XMRV in respiratory samples from 267 patients with respiratory tract infection) and 62 healthy people. After detecting XMRV in these respiratory secretions, they concluded that the “…findings indicate that XMRV or virus-infected cells might be carried in and transmitted by the respiratory tract. … Future studies should address whether the respiratory tract might serve as a source of XMRV infection or whether immunosuppression might cause an increased risk for primary infection.” (5/18/10) http://www.cdc.gov/eid/content/16/6/pdfs/10-0066.pdf This study has been reported on in nine other outlets, includingThe Brisbane Times reports that the Australian blood service will follow Canada’s suit and reviewing blood donor eligibility guidelines. Various media outlets are reporting that New Zealand health officials are doing the same. (“CFS ‘link’ prompts blood donation review”) (4/19/10) http://news.brisbanetimes.com.au/breaking-news-national/cfs-link-prompts-blood-donation-review-20100420-sr25.html This story has been reported in 18 other outlets, includingThe spring issue of The Pain Practitioner, the magazine of the American Academy of Pain Management, includes an article titled “Chronic Fatigue Syndrome” written by Association President and CEO Kimberly McCleary and Scientific Director Dr. Suzanne Vernon. [The article can be found on page 14 of the PDF or print publication.] (04/07/10) http://www.aapainmanage.org/education/EducationLit/Pain%20Practitioner%20Spring_2010.pdf The Wall Street Journal reports that “Potential Risk to Blood Supply Probed.” It opens, “An infectious virus linked to two diseases is drawing the attention of public-health officials, who are investigating the potential threat to the nation's blood supply. It isn’t clear if the virus, known as XMRV, poses a danger, and public-health officials say there isn't evidence of spreading infection. But because of concern over the potential for widespread infection and preliminary evidence that XMRV is transmitted similarly to HIV, officials are quickly trying to determine if action is needed to protect the blood supply.” (04/04/10) http://online.wsj.com/article/SB10001424052702303450704575160081295988608.html?mod=googlenews_wsj More than twenty-six media outlets and blogs have picked up this story, includingPhysical Therapy, the journal of the American Physical Therapy Association, publishes “Conceptual Model for Physical Therapist Management of Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis,” the results of a research study conducted by scientists at the University of the Pacific. The article summarizes the diagnosis of CFS and discusses the aerobic system and cognitive deficits that may affect it. It also addresses the use of graded exercise therapy as a treatment strategy and presents a new conceptual model for physical therapists to use with CFS patients. (4/01/10) The results of a study published in open-access journal PLoSOne found that raltegravir, an antiretroviral medication, was one of three such drugs that inhibited the growth of XMRV in cells in vitro. Researchers at the University of Utah and Emory University tested 45 compounds; they concluded that “combination therapy may delay or prevent the selection of resistant viruses.” (“Raltegravir Is a Potent Inhibitor of XMRV, a Virus Implicated in Prostate Cancer and Chronic Fatigue Syndrome”) (04/01/10) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0009948 Other media outlets and blogs reporting this story, now totaling more than 100, includePrevention magazine includes CFS in a list of possible causes for fatigue. (“Tired All the Time?”) (3/24/10) http://www.prevention.com/tiredallthetime/index.shtml?cm_mmc=Spotlight-_-03242010-_-Health-_-Tired%20all%20The%20Time%3f “The Race Is On,” a long article about CFS, XMRV and drug companies’ new interest in CFS appears this month in Pharmaceutical Executive, a magazine that serves the pharmaceutical and biotech industry. Writer Walter Armstrong interviewed many people for the article that provides historical context as well as a look to the horizon for treatments. (3/24/10) http://pharmexec.findpharma.com/pharmexec/article/articleDetail.jsp?id=661633&pageID=1&sk=&date The March/April 2010 issue of Lutheran Woman Today magazine includes an article about CFS, featuring interviews with Association President and CEO Kimberly McCleary and patient Wilhelmina Jenkins. It is not available online. (3/15/10) XMRV was not detected in a third follow-up study reported on February 25, 2010, in the British Medical Journal (BMJ) titled, “Prevalence of xenotropic murine leukaemia virus-related virus in patients with chronic fatigue syndrome in the Netherlands: retrospective analysis of samples from an established cohort.” Frank van Kuppeveld and an expert team of microbiologists and clinical investigators failed to find evidence of XMRV in samples from 32 CFS patients and 43 controls. So far, more than 110 publications and websites have covered the story, including: (2/25/10) http://www.bmj.com/cgi/content/full/340/feb25_1/c1018 About.com (3/02/10)A second XMRV replication study, also conducted in the UK, failed to detect the retrovirus in the blood of CFS patients, according to results published in the medical journal Retrovirology. Whittemore-Peterson Institute collaborator and CFS researcher Jonathan Kerr was involved in the study of samples from 170 patients and 395 controls. (2/15/10) http://www.retrovirology.com/content/7/1/10/abstract Other outlets, now totaling more than 70, reporting on these findings include:BBC News was the first outlet to disclose that “Research finds no proof that a virus is the cause of ME,” a report on a study published in online journal PlosOne and conducted by researchers at London’s Imperial College in which they could find no evidence of XMRV in blood samples from 186 CFS patients. This new study promises to generate nearly as much coverage as the initial study published in Science in October 2009; so far, more than 140 publications and websites have covered the story, including: (1/06/10) http://news.bbc.co.uk/2/hi/health/8441491.stm Wall Street Journal (1/07/10)The January issue of The Nurse Practitioner includes the CDC’s web-based CFS continuing education credit courses in a list of online educational resources that accompanies an article titled “E-learning resources for acute care nurse practitioners.” (01/01/2010) |
 | ||
| ||